Effects of Reduced Gag Cleavage Efficiency on HIV-1 Gag-Pol Package
Overview
Affiliations
Background: HIV-1 pol, which encodes enzymes required for virus replication, is initially translated as a Gag-Pol fusion protein. Gag-Pol is incorporated into virions via interactions with Gag precursor Pr55. Protease (PR) embedded in Gag-Pol mediates the proteolytic processing of both Pr55gag and Gag-Pol during or soon after virus particle release from cells. Since efficient Gag-Pol viral incorporation depends on interaction with Pr55 via its N-terminal Gag domain, the prevention of premature Gag cleavage may alleviate Gag-Pol packaging deficiencies associated with cleavage enhancement from PR.
Results: We engineered PR cleavage-blocking Gag mutations with the potential to significantly reduce Gag processing efficiency. Such mutations may mitigate the negative effects of enhanced PR activation on virus assembly and Gag-Pol packaging due to an RT dimerization enhancer or leucine zipper dimerization motif. When co-expressed with Pr55, we noted that enhanced PR activation resulted in reduced Gag-Pol cis or trans incorporation into Pr55 particles, regardless of whether or not Gag cleavage sites within Gag-Pol were blocked.
Conclusions: Our data suggest that the amount of HIV-1 Gag-Pol or Pol viral incorporation is largely dependent on virus particle production, and that cleavage blocking in the Gag-Pol N-terminal Gag domain does not exert significant impacts on Pol packaging.
Exploring HIV-1 Maturation: A New Frontier in Antiviral Development.
McGraw A, Hillmer G, Medehincu S, Hikichi Y, Gagliardi S, Narayan K Viruses. 2024; 16(9).
PMID: 39339899 PMC: 11437483. DOI: 10.3390/v16091423.
Marie V, Gordon M Int J Mol Sci. 2022; 23(14).
PMID: 35886917 PMC: 9323242. DOI: 10.3390/ijms23147569.